| Pharmaceutical compositions of ghrh analogs and uses thereof |
2022-6-22 |
2022-12-01 |
|
| Sortilin binding conjugate compounds, compositions and uses thereof for … |
2022-6-02 |
2022-8-01 |
|
| Methods and sortilin binding conjugate compounds for targeting cancer stem … |
2022-2-24 |
2022-9-01 |
|
| Low-dose pharmaceutical compositions of GHRH analogs and uses thereof |
2021-6-30 |
2023-1-19 |
|
| Pharmaceutical compositions of ghrh analogs and uses thereof |
2019-3-22 |
2020-9-22 |
|
| Formulations of growth hormone releasing factor (grf) molecules with improved … |
2014-2-26 |
2016-12-21 |
|
| Halogenated rhodamine derivatives and applications thereof |
2013-1-28 |
2017-5-02 |
2017-5-02 |
| melantransferrin-derived peptide compounds and uses thereof |
2012-10-18 |
2017-6-06 |
|
| Peptides And Peptidomimetics Useful For Suspending Prostaglandin F2a Receptor … |
2012-10-17 |
2016-6-22 |
|
| ANALOGS OF THE GROWTH HORMONE RELEASE FACTOR (GRF) AND ITS USES |
2012-4-19 |
2014-4-16 |
|
| Assessment of igf-1 levels in hiv-infected subjects and uses thereof |
2012-1-11 |
2012-7-19 |
|
| Gh secretagogues and uses thereof |
2011-7-07 |
2012-1-05 |
|
| Peptides and peptidomimetics useful for inhibiting the activity of … |
2011-4-28 |
2012-11-22 |
2012-11-22 |
| Peptides and peptidomimetics useful for inhibiting the activity of … |
2011-4-28 |
2011-5-19 |
|
| Selection and treatment of patients suffering from wasting |
2011-1-11 |
2011-5-05 |
|
| Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy |
2010-4-20 |
2012-2-29 |
|
| Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy |
2010-4-20 |
2012-2-29 |
|
| Bifunctional fusion proteins of the alpha - melanocyte stimulating hormone ( … |
2009-12-09 |
2011-8-01 |
|
| Method and compound for prevention and treatment of elevated intraocular … |
2009-12-02 |
2010-4-08 |
|
| Pharmaceutical formulations of ghrh molecules |
2009-9-08 |
2010-5-17 |
|
| Gh secretagogues and uses thereof gh |
2008-6-04 |
2008-12-12 |
|
| Synthetic nucleic acid molecule compositions and methods of preparation |
2007-7-05 |
2011-8-30 |
2011-8-30 |
| Substance that promotes GH secretion and its use |
2007-4-24 |
2007-7-16 |
|
| Modulators of fatty acid-stimulated insulin secretion and uses thereof |
2005-2-23 |
2005-9-01 |
|
| Modulators of blood glucose levels and uses thereof |
2005-2-23 |
2005-9-01 |
|
| Long-acting glucagon-like peptide-1 analogs |
2005-1-07 |
2007-5-02 |
|
| Glucagon-like peptide-1 analogs with long duration of action |
2005-1-07 |
2007-2-07 |
|
| Use of ghrelin and unacylated ghrelin compostions in insulin-related disease … |
2004-10-22 |
2005-5-06 |
|
| Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
2004-10-19 |
2008-8-19 |
2008-8-19 |
| Compounds that modulate the glucagon response and uses thereof |
2004-6-18 |
2004-12-23 |
|
| Use of melanotransferrin (p97) for regulating plasminogen activation and cell … |
2004-5-07 |
2014-5-27 |
2014-5-27 |
| Chemically modified metabolites of regulatory peptides and methods of producing … |
2004-1-30 |
2005-3-17 |
|
| Modified GLP-1 peptides with increased biological potency |
2003-9-25 |
2004-7-01 |
|
| Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
2003-5-23 |
2003-12-12 |
|
| Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
2003-5-23 |
2008-2-20 |
|
| PTH derivatives resistant to skin proteases |
2003-5-16 |
2004-2-05 |
|
| Pharmaceutical compositions comprising unacylated ghrelin and therapeutical … |
2002-12-18 |
2003-6-30 |
|
| Pharmaceutical compositions comprising unacylated ghrelin and therapeutical … |
2002-12-18 |
2003-6-26 |
|
| "Rhodamine derivative, pharmaceutical composition, intermediate, and, process … |
2002-3-27 |
2021-5-25 |
|
| Modified peptides with increased potency |
2001-8-02 |
2003-5-02 |
|